nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGA—Podofilox—Etoposide—peripheral nervous system neoplasm	0.021	1	CbGdCrCtD
Sucralfate—Haemolysis—Cisplatin—peripheral nervous system neoplasm	0.0185	0.0558	CcSEcCtD
Sucralfate—Fluid overload—Tretinoin—peripheral nervous system neoplasm	0.0147	0.0442	CcSEcCtD
Sucralfate—Fluid overload—Isotretinoin—peripheral nervous system neoplasm	0.0147	0.0442	CcSEcCtD
Sucralfate—Lung disorder—Topotecan—peripheral nervous system neoplasm	0.013	0.0392	CcSEcCtD
Sucralfate—Lung disorder—Tretinoin—peripheral nervous system neoplasm	0.0129	0.0388	CcSEcCtD
Sucralfate—Lung disorder—Isotretinoin—peripheral nervous system neoplasm	0.0129	0.0388	CcSEcCtD
Sucralfate—Fluid overload—Alitretinoin—peripheral nervous system neoplasm	0.0111	0.0335	CcSEcCtD
Sucralfate—Venous thrombosis—Cisplatin—peripheral nervous system neoplasm	0.0109	0.0329	CcSEcCtD
Sucralfate—Extravasation—Topotecan—peripheral nervous system neoplasm	0.0105	0.0318	CcSEcCtD
Sucralfate—Extravasation—Melphalan—peripheral nervous system neoplasm	0.0103	0.0311	CcSEcCtD
Sucralfate—Lung disorder—Alitretinoin—peripheral nervous system neoplasm	0.00977	0.0294	CcSEcCtD
Sucralfate—Fluid overload—Cisplatin—peripheral nervous system neoplasm	0.00947	0.0286	CcSEcCtD
Sucralfate—Extravasation—Dactinomycin—peripheral nervous system neoplasm	0.00855	0.0258	CcSEcCtD
Sucralfate—Phlebitis—Tretinoin—peripheral nervous system neoplasm	0.00769	0.0232	CcSEcCtD
Sucralfate—Phlebitis—Isotretinoin—peripheral nervous system neoplasm	0.00769	0.0232	CcSEcCtD
Sucralfate—Extravasation—Vincristine—peripheral nervous system neoplasm	0.00764	0.023	CcSEcCtD
Sucralfate—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.00675	0.0203	CcSEcCtD
Sucralfate—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.00656	0.0198	CcSEcCtD
Sucralfate—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.00628	0.0189	CcSEcCtD
Sucralfate—Extravasation—Etoposide—peripheral nervous system neoplasm	0.00619	0.0186	CcSEcCtD
Sucralfate—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.00583	0.0176	CcSEcCtD
Sucralfate—Venous thrombosis—Epirubicin—peripheral nervous system neoplasm	0.00561	0.0169	CcSEcCtD
Sucralfate—Venous thrombosis—Doxorubicin—peripheral nervous system neoplasm	0.00519	0.0156	CcSEcCtD
Sucralfate—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.00496	0.015	CcSEcCtD
Sucralfate—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.00486	0.0146	CcSEcCtD
Sucralfate—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.00455	0.0137	CcSEcCtD
Sucralfate—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00429	0.0129	CcSEcCtD
Sucralfate—Lung disorder—Epirubicin—peripheral nervous system neoplasm	0.00427	0.0129	CcSEcCtD
Sucralfate—Lung disorder—Doxorubicin—peripheral nervous system neoplasm	0.00396	0.0119	CcSEcCtD
Sucralfate—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.00347	0.0105	CcSEcCtD
Sucralfate—Infection—Topotecan—peripheral nervous system neoplasm	0.00326	0.00982	CcSEcCtD
Sucralfate—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00326	0.00981	CcSEcCtD
Sucralfate—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00326	0.00981	CcSEcCtD
Sucralfate—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00323	0.00975	CcSEcCtD
Sucralfate—Infection—Tretinoin—peripheral nervous system neoplasm	0.00323	0.00975	CcSEcCtD
Sucralfate—Oedema—Melphalan—peripheral nervous system neoplasm	0.00321	0.00968	CcSEcCtD
Sucralfate—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00321	0.00967	CcSEcCtD
Sucralfate—Infection—Melphalan—peripheral nervous system neoplasm	0.00319	0.00962	CcSEcCtD
Sucralfate—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00266	0.00802	CcSEcCtD
Sucralfate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00264	0.00797	CcSEcCtD
Sucralfate—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00259	0.00782	CcSEcCtD
Sucralfate—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00257	0.00775	CcSEcCtD
Sucralfate—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.00775	CcSEcCtD
Sucralfate—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00255	0.00768	CcSEcCtD
Sucralfate—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00247	0.00743	CcSEcCtD
Sucralfate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00245	0.00739	CcSEcCtD
Sucralfate—Oedema—Vincristine—peripheral nervous system neoplasm	0.00238	0.00716	CcSEcCtD
Sucralfate—Infection—Vincristine—peripheral nervous system neoplasm	0.00236	0.00712	CcSEcCtD
Sucralfate—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00236	0.00711	CcSEcCtD
Sucralfate—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00221	0.00665	CcSEcCtD
Sucralfate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.0021	0.00634	CcSEcCtD
Sucralfate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.0021	0.00633	CcSEcCtD
Sucralfate—Infection—Cisplatin—peripheral nervous system neoplasm	0.00209	0.00629	CcSEcCtD
Sucralfate—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00204	0.00615	CcSEcCtD
Sucralfate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00588	CcSEcCtD
Sucralfate—Infection—Etoposide—peripheral nervous system neoplasm	0.00191	0.00577	CcSEcCtD
Sucralfate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00188	0.00566	CcSEcCtD
Sucralfate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00166	0.00501	CcSEcCtD
Sucralfate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00152	0.00459	CcSEcCtD
Sucralfate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00325	CcSEcCtD
Sucralfate—Infection—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00323	CcSEcCtD
Sucralfate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000999	0.00301	CcSEcCtD
Sucralfate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000992	0.00299	CcSEcCtD
Sucralfate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000853	0.00257	CcSEcCtD
Sucralfate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00079	0.00238	CcSEcCtD
Sucralfate—FGF2—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	0.000349	0.000539	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000348	0.000538	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	0.000347	0.000536	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000346	0.000534	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000346	0.000534	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.000345	0.000533	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000345	0.000533	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000344	0.000532	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—NRAS—peripheral nervous system neoplasm	0.000344	0.000531	CbGpPWpGaD
Sucralfate—EGF—Immune System—IFNB1—peripheral nervous system neoplasm	0.000341	0.000527	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	0.000339	0.000523	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—AKT1—peripheral nervous system neoplasm	0.000335	0.000518	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000334	0.000517	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—HRAS—peripheral nervous system neoplasm	0.000332	0.000512	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000331	0.000511	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.00033	0.00051	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.00033	0.00051	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.00033	0.00051	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.00033	0.00051	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000328	0.000506	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000328	0.000506	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—AKT1—peripheral nervous system neoplasm	0.000327	0.000505	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000327	0.000505	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	0.000324	0.000501	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000324	0.000501	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD34—peripheral nervous system neoplasm	0.000324	0.0005	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000323	0.000499	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	0.000323	0.000499	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—NRAS—peripheral nervous system neoplasm	0.000323	0.000499	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000323	0.000499	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	0.00032	0.000495	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000319	0.000493	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000318	0.000492	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000317	0.000491	CbGpPWpGaD
Sucralfate—EGF—Disease—SLC2A1—peripheral nervous system neoplasm	0.000317	0.00049	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	0.000317	0.00049	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000317	0.00049	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	0.000316	0.000488	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000312	0.000483	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000312	0.000483	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—AKT1—peripheral nervous system neoplasm	0.000312	0.000482	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000312	0.000481	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.00031	0.00048	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000305	0.000472	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.000299	0.000462	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000292	0.000452	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000292	0.000452	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000289	0.000447	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000288	0.000445	CbGpPWpGaD
Sucralfate—FGF2—Disease—PPP3R1—peripheral nervous system neoplasm	0.000288	0.000445	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000287	0.000443	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000287	0.000443	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000286	0.000442	CbGpPWpGaD
Sucralfate—FGA—Disease—PTPN11—peripheral nervous system neoplasm	0.000284	0.000439	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000284	0.000438	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000283	0.000438	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.00028	0.000433	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000276	0.000427	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000276	0.000427	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—peripheral nervous system neoplasm	0.000276	0.000426	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NCAM1—peripheral nervous system neoplasm	0.000275	0.000425	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	0.000271	0.000419	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—peripheral nervous system neoplasm	0.00027	0.000417	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—peripheral nervous system neoplasm	0.00027	0.000417	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.00027	0.000417	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000267	0.000413	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000264	0.000408	CbGpPWpGaD
Sucralfate—EGF—Immune System—HGF—peripheral nervous system neoplasm	0.000263	0.000407	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000263	0.000406	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000261	0.000403	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000258	0.000399	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000258	0.000399	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000258	0.000398	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000257	0.000397	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MET—peripheral nervous system neoplasm	0.000256	0.000395	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	0.000255	0.000394	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000255	0.000393	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	0.000254	0.000392	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000253	0.00039	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—HRAS—peripheral nervous system neoplasm	0.000251	0.000388	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.00025	0.000387	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.00025	0.000387	CbGpPWpGaD
Sucralfate—FGF2—Disease—ENO2—peripheral nervous system neoplasm	0.000249	0.000385	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.000248	0.000383	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000247	0.000382	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.00024	0.00037	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000239	0.000369	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000236	0.000365	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.000236	0.000365	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.000236	0.000365	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.000236	0.000365	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.000236	0.000364	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000234	0.000362	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000233	0.00036	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000233	0.000359	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000232	0.000359	CbGpPWpGaD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000232	0.000358	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.000231	0.000357	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000228	0.000353	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000228	0.000353	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000225	0.000348	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000225	0.000348	CbGpPWpGaD
Sucralfate—FGA—Disease—ERBB2—peripheral nervous system neoplasm	0.000225	0.000347	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000225	0.000347	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.000224	0.000346	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000223	0.000345	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000222	0.000343	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—NRAS—peripheral nervous system neoplasm	0.00022	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.00022	0.00034	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000219	0.000338	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000219	0.000338	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000218	0.000337	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNB1—peripheral nervous system neoplasm	0.000216	0.000334	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000209	0.000324	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000209	0.000323	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000209	0.000323	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.000209	0.000323	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000209	0.000323	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000207	0.00032	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000205	0.000317	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000204	0.000316	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000204	0.000316	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000203	0.000314	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000201	0.000311	CbGpPWpGaD
Sucralfate—FGF2—Disease—SLC2A1—peripheral nervous system neoplasm	0.000201	0.00031	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000201	0.00031	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000199	0.000308	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000199	0.000308	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000198	0.000307	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000198	0.000307	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000196	0.000304	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000195	0.000301	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000193	0.000299	CbGpPWpGaD
Sucralfate—EGF—Immune System—PTPN11—peripheral nervous system neoplasm	0.000192	0.000297	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.000191	0.000294	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000187	0.000289	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000185	0.000286	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000179	0.000276	CbGpPWpGaD
Sucralfate—EGF—Disease—PTPN11—peripheral nervous system neoplasm	0.000177	0.000274	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000174	0.000268	CbGpPWpGaD
Sucralfate—FGA—Disease—NRAS—peripheral nervous system neoplasm	0.000171	0.000264	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—peripheral nervous system neoplasm	0.000169	0.000261	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HGF—peripheral nervous system neoplasm	0.000167	0.000258	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000165	0.000255	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000161	0.000249	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000161	0.000249	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000161	0.000248	CbGpPWpGaD
Sucralfate—FGA—Disease—MYC—peripheral nervous system neoplasm	0.000159	0.000246	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.000158	0.000245	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000157	0.000243	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000157	0.000243	CbGpPWpGaD
Sucralfate—EGF—Immune System—ERBB2—peripheral nervous system neoplasm	0.000152	0.000235	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000151	0.000234	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00015	0.000232	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000146	0.000225	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000145	0.000224	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000144	0.000223	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000143	0.000221	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000143	0.000221	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000142	0.00022	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000142	0.00022	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000142	0.00022	CbGpPWpGaD
Sucralfate—EGF—Disease—ERBB2—peripheral nervous system neoplasm	0.00014	0.000217	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	0.000139	0.000215	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000139	0.000215	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000131	0.000202	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000129	0.0002	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000128	0.000198	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GNS—peripheral nervous system neoplasm	0.000126	0.000194	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000126	0.000194	CbGpPWpGaD
Sucralfate—FGA—Disease—HRAS—peripheral nervous system neoplasm	0.000125	0.000193	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000124	0.000192	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000123	0.000191	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	0.000123	0.00019	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000122	0.000189	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000122	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTPN11—peripheral nervous system neoplasm	0.000122	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.000121	0.000186	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NME1—peripheral nervous system neoplasm	0.00012	0.000186	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00012	0.000185	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00012	0.000185	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	0.000116	0.000179	CbGpPWpGaD
Sucralfate—ALB—Metabolism—COX2—peripheral nervous system neoplasm	0.000116	0.000179	CbGpPWpGaD
Sucralfate—EGF—Immune System—NRAS—peripheral nervous system neoplasm	0.000116	0.000179	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000114	0.000176	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000113	0.000175	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTPN11—peripheral nervous system neoplasm	0.000112	0.000174	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000112	0.000172	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000112	0.000172	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—peripheral nervous system neoplasm	0.00011	0.000171	CbGpPWpGaD
Sucralfate—EGF—Disease—NRAS—peripheral nervous system neoplasm	0.000107	0.000165	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000105	0.000163	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000104	0.000161	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000103	0.00016	CbGpPWpGaD
Sucralfate—EGF—Disease—MYC—peripheral nervous system neoplasm	9.94e-05	0.000154	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.82e-05	0.000152	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERBB2—peripheral nervous system neoplasm	9.61e-05	0.000149	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.35e-05	0.000144	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HRAS—peripheral nervous system neoplasm	9.19e-05	0.000142	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—peripheral nervous system neoplasm	9.18e-05	0.000142	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.16e-05	0.000142	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.16e-05	0.000142	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.94e-05	0.000138	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.91e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Disease—ERBB2—peripheral nervous system neoplasm	8.88e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	8.82e-05	0.000136	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.76e-05	0.000135	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.76e-05	0.000135	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	8.46e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Immune System—HRAS—peripheral nervous system neoplasm	8.45e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.11e-05	0.000125	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.89e-05	0.000122	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.86e-05	0.000122	CbGpPWpGaD
Sucralfate—EGF—Disease—HRAS—peripheral nervous system neoplasm	7.81e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	7.79e-05	0.00012	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.73e-05	0.00012	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.73e-05	0.00012	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	7.61e-05	0.000118	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.47e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—peripheral nervous system neoplasm	7.47e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NRAS—peripheral nervous system neoplasm	7.31e-05	0.000113	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.96e-05	0.000108	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—peripheral nervous system neoplasm	6.89e-05	0.000107	CbGpPWpGaD
Sucralfate—FGF2—Disease—NRAS—peripheral nervous system neoplasm	6.75e-05	0.000104	CbGpPWpGaD
Sucralfate—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	6.43e-05	9.94e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.37e-05	9.85e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MYC—peripheral nervous system neoplasm	6.29e-05	9.72e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.22e-05	9.6e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.13e-05	9.48e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TH—peripheral nervous system neoplasm	6.05e-05	9.34e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.72e-05	8.83e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.64e-05	8.72e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.47e-05	8.45e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HRAS—peripheral nervous system neoplasm	5.35e-05	8.27e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	5.09e-05	7.86e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—HRAS—peripheral nervous system neoplasm	4.94e-05	7.63e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	4.93e-05	7.63e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	4.84e-05	7.48e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.83e-05	7.46e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.73e-05	7.31e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—peripheral nervous system neoplasm	4.72e-05	7.3e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.4e-05	6.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—peripheral nervous system neoplasm	4.36e-05	6.74e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	3.89e-05	6.01e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	3.72e-05	5.75e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.62e-05	5.59e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.46e-05	5.35e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	3.29e-05	5.08e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.05e-05	4.72e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.33e-05	2.06e-05	CbGpPWpGaD
